TomoWave Medical Group is dedicated to advancing and applying cutting-edge 3D/4D Photoacoustic Tomography (PAT) technology. This innovative technology enables structural, functional, and molecular imaging through its exceptional resolution, contrast, and sensitivity. It facilitates real-time, image-guided animal experiments and enables non-invasive, synchronous image-guided biopsies and surgeries. As a leader in the research, development, and production of photoacoustic tomography imaging equipment, TomoWave has successfully launched two pioneering product lines: the Preclinical Animal Photoacoustic Imaging System and the Clinical Photoacoustic Diagnostic System. Notably, the Preclinical Animal Photoacoustic Imaging System has achieved significant commercial success, with sales exceeding 3.5 million USD.

​

www.tomowave.com